Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Patient Education Webcasts
Coffee With LLS: Let’s Talk About COVID
News
LLS Invests in Solutions to Advance Health Equity
More than $1.3 million awarded through new LLS Equity in Access Research Program
News
How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm
How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm
Research
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)
SANTA MONICA, Calif. April 1, 2022 - Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved Y…
Research
Faron Pharmaceuticals Announces the Private Placement of EUR 5 Million, Including LLS TAP
TURKU, FINLAND / BOSTON, MA, June 28, 2022 - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company foc…
News
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
News
The Leukemia & Lymphoma Society Launches First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
The global leader in the fight against blood cancers, The Leukemia & Lymphoma Society (LLS), announced the launch of its Pediatric Acute Leukemia (Ped…
News
LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
LLS Remains Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
